(Q44798182)

English

Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized, multicenter, double-blind clinical trial

scientific article published in April 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 December 2017

Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized, multicenter, double-blind clinical trial (English)

1 reference

Europe PubMed Central

6 December 2017

multicenter clinical trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Stephen D Shafran

1

1 reference

Europe PubMed Central

6 December 2017

Stephen K Tyring

2

1 reference

Europe PubMed Central

6 December 2017

Richard Ashton

3

1 reference

Europe PubMed Central

6 December 2017

Jacque Decroix

4

1 reference

Europe PubMed Central

6 December 2017

Chistine Forszpaniak

5

1 reference

Europe PubMed Central

6 December 2017

Alan Wade

6

1 reference

Europe PubMed Central

6 December 2017

Christian Paulet

7

1 reference

Europe PubMed Central

6 December 2017

Daniel Candaele

8

1 reference

Europe PubMed Central

6 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 April 2004

1 reference

Europe PubMed Central

6 December 2017

Journal of Clinical Virology

1 reference

Europe PubMed Central

6 December 2017

29

1 reference

Europe PubMed Central

6 December 2017

4

1 reference

Europe PubMed Central

6 December 2017

248-253

1 reference

Europe PubMed Central

6 December 2017

Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900164-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiology of varicella zoster virus infection in Canada and the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900164-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of acyclovir after intravenous and oral administration.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900164-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors influencing pain outcome in herpes zoster: an observational study with valaciclovir. Valaciclovir International Zoster Assessment Group (VIZA).

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900164-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Famciclovir, a new oral antiherpes drug: results of the first controlled clinical study demonstrating its efficacy and safety in the treatment of uncomplicated herpes zoster in immunocompetent patients

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900164-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical applications for change-point analysis of herpes zoster pain

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900164-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The incidence of herpes zoster

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900164-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute pain in herpes zoster: the famciclovir database project

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900164-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900164-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A sharper Bonferroni procedure for multiple tests of significance

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900164-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Herpes zoster--predicting and minimizing the impact of post-herpetic neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900164-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Lack of effect of acyclovir on postherpetic neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900164-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Famciclovir for the Treatment of Acute Herpes Zoster: Effects on Acute Disease and Postherpetic Neuralgia: A Randomized, Double-Blind, Placebo-Controlled Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900164-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiviral therapy for herpes zoster: randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900164-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction of postherpetic neuralgia in herpes zoster

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900164-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Herpes zoster: risk categories for persistent pain

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900164-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900164-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1386-6532(03)00164-1

1 reference

Europe PubMed Central

6 December 2017

release_pfrjibsuc5bxtffx252vlfl37i

1 reference

https://api.fatcat.wiki/v0/release/pfrjibsuc5bxtffx252vlfl37i

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

6 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44798182&oldid=2043313568"